12 research outputs found
Celexocib (200 MG/D) or diclofenac (100 MG/D) in osteoarthritis: A multicentre, double blind trial
Annual European Congress of Rheumatology -- 37790 -- LISBON, PORTUGALWOS: 000224551400849
Gastrointestinal side effect profile due to the use of alendronate in the treatment of osteoporosis
The aim of our study was to evaluate the upper gastrointestinal (GI) tract side effect profile in 759 female patients that had taken alendronate (10 mg/day), for at least 6 months, for the treatment of osteoporosis, in relation to the safety of alendronate and the compliance of patients to its absorption rules